Role of variants rs5030717 and rs5030718 of TLR4 in the risk prediction of nephropathy, hypertension and dyslipidaemia in type 2 diabetes mellitus

References

• Krentz AJ , Clough G , Byrne CD . Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab. 2007;9:781–791.10.1111/dom.2007.9.issue-6
   PubMed Web of Science ®Google Scholar
• Al-Wakeel JS , Hammad D , Al SA , et al . Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic. Saudi J Kidney Dis Transpl. 2009;20:77–85.
   PubMedGoogle Scholar
• World Health Organization . World health day 2016. Diabetes; 2016. Available from: http://www.searo.who.int
   Google Scholar
• International Diabetes Federation . IDF Atlas. 7th ed. [Last accessed on 2015 Dec 27]. Available from: http://www.diabetesatlas.org
   Google Scholar
• Beckman JA , Creager MA , Libby P . Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J Amer Med Assoc. 2002;287(19):2570–2581.10.1001/jama.287.19.2570
   PubMed Web of Science ®Google Scholar
• Schmitt-Koopmann I , Schwenkglenks M , Spinas GA , et al . Direct medical costs of type 2 diabetes and its complications in Switzerland. Eur J Public Health. 2004;14(1):3–9.10.1093/eurpub/14.1.3
   PubMed Web of Science ®Google Scholar
• Simpson SH , Corabian P , Jacobs P , et al . The cost of major comorbidity in people with diabetes mellitus. Canad Med Assoc J. 2003;168(13):1661–1667.
   Web of Science ®Google Scholar
• Rashid M , Anandhasayanam A , Kannan S , et al . Prevalence of co-morbidities in type 2 diabetes mellitus patients, the awareness level and the impact of pharmacist’s patient education program. Int J Pharma Research Review. 2015;4(5):11–20.
   Google Scholar
• Pelletier EM , Shim B , Ben-Joseph R , et al . Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis. PharmacoEconomics. 2009;27(6):479–490.10.2165/00019053-200927060-00004
   PubMed Web of Science ®Google Scholar
• Atlanta GA . National estimates and general information on diabetes and prediabetes in the United States. National Diabetes fact sheet: 2011; https://www.cdc.gov/diabetes
   Google Scholar
• Gay NJ , Gangloff M . Structure and function of toll receptors and their ligands. Annu Rev Biochem. 2007;76:141–165.10.1146/annurev.biochem.76.060305.151318
   PubMed Web of Science ®Google Scholar
• Akira S . Toll receptor families: structure and function. Semin Immunol. 2004;16:1–2.10.1016/j.smim.2003.10.001
   PubMed Web of Science ®Google Scholar
• Aderem A , Ulevitch RJ . Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782–787.10.1038/35021228
   PubMed Web of Science ®Google Scholar
• Mukherjee S , Biswas T . Activation of TOLLIP by porin prevents TLR2-associated IFN-gamma and TNF-alpha-induced apoptosis of intestinal epithelial cells. Cellular Signalling. 2014;26:2674–2682.10.1016/j.cellsig.2014.08.009
   PubMed Web of Science ®Google Scholar
• Jeon JW , Ha UH , Paek SH . In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing. PLoS ONE. 2014;9(8):e105212.10.1371/journal.pone.0105212
   PubMed Web of Science ®Google Scholar
• Starkhammar M , Larsson O , Kumlien Georen S , et al . Toll-like receptor ligands LPS and poly (I:C) exacerbate airway hyperresponsiveness in a model of airway allergy in mice, independently of inflammation. PLoS ONE. 2014;9(8):e104114.10.1371/journal.pone.0104114
   PubMed Web of Science ®Google Scholar
• Festa A , D’agostino R , Howard G , et al . Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation. 2000;102:42–47.10.1161/01.CIR.102.1.42
   PubMed Web of Science ®Google Scholar
• Navarro JF , Mora C . Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Scientific World J. 2006;6:908–917.10.1100/tsw.2006.179
   Google Scholar
• Jiang Z-S , Wang S , Jia HX , et al . Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus. Inflammation. 2013;36(1):251–257.10.1007/s10753-012-9541-7
   PubMed Web of Science ®Google Scholar
• Arora P , Garcia-Bailo B , Dastani Z , et al. Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet. 2011; 12: 95.10.1186/1471-2350-12-95
   PubMed Web of Science ®Google Scholar
• Jiang ZS , Wang SX , Jia HX , et al . Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus. Inflammation. 2013;36:251–257.10.1007/s10753-012-9541-7
   PubMed Web of Science ®Google Scholar
• Bagarolli RA , Saad MJ , Saad ST . Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with Type 2 diabetes. J Diabetes Complications. 2010;24:192–198.10.1016/j.jdiacomp.2009.03.003
   PubMed Web of Science ®Google Scholar
• Illig T, Bongardt F, Schöpfer A, et al. The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes. 2003;52:2861–2864.10.2337/diabetes.52.11.2861
   PubMed Web of Science ®Google Scholar
• Kolek MJ , Carlquist JF , Muhlestein JB , et al . Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes. Am Heart J. 2004;148:1034–1040.10.1016/j.ahj.2004.05.049
   PubMed Web of Science ®Google Scholar
• Manolakis AC , Kapsoritakis AN , Tiaka EK , et al . TLR4 gene polymorphisms: evidence for protection against type 2 diabetes but not for diabetes-associated ischaemic heart disease. Eur J Endocrinol. 2011;165:261–267.10.1530/EJE-11-0280
   PubMed Web of Science ®Google Scholar
• Belforte FS , Coluccio Leskow F , Poskus E . Toll-like receptor 4 D299G polymorphism in metabolic disorders: a meta-analysis. Mol Biol Rep. 2013;40:3015–3020.10.1007/s11033-012-2374-5
   PubMed Web of Science ®Google Scholar
• Wilkin TJ . The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. Int J Obesity. 2009;33(7):716–726.10.1038/ijo.2009.97
   Web of Science ®Google Scholar
• Sullivan PW , Morrato EH , Ghushchyan V , et al . Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000–2002. Diabetes Care. 2005;28(7):1599–1603.10.2337/diacare.28.7.1599
   PubMed Web of Science ®Google Scholar
• Prokopenko I , McCarthy MI . Lindgren CM type 2 diabetes: new genes, new understanding. Trends Genet. 2008;24:613–621.10.1016/j.tig.2008.09.004
   PubMed Web of Science ®Google Scholar
• Rizvi S , Raza ST , Mahdi F , et al. Genetic polymorphism in KNCJ11 (E23K, rs5219) and SDF-1β (G801A, rs1801157) genes are associated with the risk of type 2 diabetes mellitus. Br J Biomed Sci. 2018;75(3):139–144.
   PubMed Web of Science ®Google Scholar
• Weyrich P , Staiger H , Stancakova A , et al . The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies. PLoS One 2010; 5:e13980.
   PubMed Web of Science ®Google Scholar
• Zaharieva ET , Kamenov ZA , Savov AS . TLR4 polymorphisms seem not to be associated with prediabetes and type 2 diabetes but predispose to diabetic retinopathy; TLR4 polymorphisms in glucose continuum. Endocrine Regulations. 2017;51(3):137–144.
   PubMedGoogle Scholar
• Fu XD , Sun XQ , Wang HY , et al . Genetic polymorphisms of the TLR4 gene and their association with susceptibility to type 2 diabetes mellitus in the Chinese population Genet. Mol Res. 2013;12(3):3813–3820.10.4238/2013.September.19.13
   PubMed Web of Science ®Google Scholar
• Zhou L , Zheng D , Wang S , et al. Genetic association of Toll‑like receptor 4 gene and coronary artery disease in a Chinese Han population. SpringerPlus. 2016; 5:1533, doi: 10.1186/s40064-016-3177-2
   PubMedGoogle Scholar
• Peng D , Wang J , Pan J , et al . Lack of Association between TLR4 Genetic Polymorphisms and Diabetic Nephropathy in a Chinese Population. BioMed Res Int. 2014; 704167. doi: 10.1155/2014/704167.
   PubMed Web of Science ®Google Scholar
• Kuwabara T , Mori K , Mukoyama M , et al . Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia. 2012;55(8):2256–2266.10.1007/s00125-012-2578-1
   PubMed Web of Science ®Google Scholar
• Cuda C , Badawi A , Karmali M , et al . Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol. Metabolism. 2011;60:1131–1135.10.1016/j.metabol.2010.12.006
   PubMed Web of Science ®Google Scholar
• Schneider, KW , Hoppmann P , Ubrich R , et al. Association of Toll-like receptor 4 polymorphism with age-dependent systolic blood pressure increase in patients with coronary artery disease. Immunity Ageing. 2015;12:4. doi: 10.1186/s12979-015-0031-2
   PubMed Web of Science ®Google Scholar
• Schneider S , Hoppmann P , Koch W , et al . Obesity-associated hypertension is ameliorated in patients with TLR4 single nucleotide polymorphism (SNP) rs4986790. J Inflamm. 2015;12:57. doi:10.1186/s12950-015-0100-5.
   Google Scholar
• Szabo M , Máté B , Csép K , et al. Genetic approaches to the study of gene variants and their impact on the pathophysiology of type 2 diabetes. Biochem Genetics. 2018;56:22–55.10.1007/s10528-017-9827-4
   PubMed Web of Science ®Google Scholar